Since its inception, BioGenerator has invested $39 million into more than 100 St. Louis bioscience companies that have collectively raised $2.6 billion in follow-on capital, with 85 percent of that funding coming from outside the St. Louis region. The organization has leveraged $68 for every $1 it has invested, positioning BioGenerator as one of the leading US entrepreneur support organizations. BioGenerator’s 60+ active portfolio companies span sectors including therapeutics, agtech, research tools and services, diagnostics, medical devices, and healthcare.
Learn more about BioGenerator Ventures and BioGenerator Labs at BioGenerator.org.
Watch at BioSTL →
